Supplementation with the co-enzyme Ubiquinone Q10 can “significantly improve” blood sugar control in Type 2 diabetics, as well as helping sufferers who take statins or have non-alcoholic fatty liver disease (NAFLD), according to an article in The British Journal of Diabetes.
The study comes in the wake of figures showing diabetes as the fastest growing health crisis in the UK with the number of sufferers doubling to 3.7 million in the last 20 years with a further 12.3 million at increased risk of developing Type 2 diabetes.
The co-enzyme Ubiquinone Q10 is a vitamin-like substance which plays a vital role in the body’s energy supply mechanism, acting alongside enzymes converting fats and sugars into energy.
Heart and skeletal muscles have the highest energy requirements of all tissues and are particularly reliant on adequate supplies of Q10 as a result.
GETTYType 2 diabetes: Supplements containing this enzyme could help manage condition's symptomsiPhone transfer software Related articles
Supplementation with the co-enzyme Ubiquinone Q10 can “significantly improve” blood sugar control in Type 2 diabetics
Ubiquinone Q10 is also an antioxidant, protecting cells from the potentially damaging effects of toxic free radicals, but production of Ubiquinone Q10 in the body declines with age and Type 2 diabetics are often found to have lower levels of the substance.
The British Journal of Diabetes piece on Ubiquinone Q10 and diabetes pointed to a number of different clinical studies which showed how Type 2 diabetes sufferers who took Ubiquinone Q10 supplements of between 100mg and 200mg a day over a two to three-month period saw their conditions improve.
The results included:Significantly improved long-term blood sugar and blood pressure control 1 Significantly reduced glycated haemoglobon (HbA1c) levels, thereby reducing the risk of